@FiercePharma: Why are Anoro & Breo slow starters? GSK's new quota-free model, critics say. More | Follow @FiercePharma
@TracyStaton: On Pfizer, the market's focus is on EPS beat. 58 cents vs. expected 57. Shares up 1.3% pre-market. Release | Follow @TracyStaton
@EricPFierce: Impax shares take a thrashing after FDA issues Taiwan plant new Form 483 with 10 observations. Article | Follow @EricPFierce
@CarlyHFierce: Merck spokeswoman: Sales layoffs to hit PA-based field reps. Story | Follow @CarlyHFierce
> Roche ($RHHBY) won European approval for its chronic lymphocytic leukemia treatment, Gazyvaro, in another step toward turning the drug into a blockbuster successor to Rituxan. Release | Report (sub. req.)
> Despite GlaxoSmithKline's ($GSK) disappointing second-quarter results, analysts figure that its dividend is likely safe, at least for now. Report
> Ranbaxy Laboratories suffered a quarterly loss after yet another import ban because of quality problems at an Indian plant. Report
> Recent hedge fund filings show that U.S. drugmaker Bristol-Myers Squibb ($BMY) has fans in that slice of the investment world. Report
> Italy's Recordati boosted profits by 18% in the first half of 2014, thanks to a 6% increase in sales, to €507.6 million. Report
> Brazilian drugmaker Hypermarcas doesn't see any ripe opportunities for dealmaking, CEO Claudio Bergamo says. Report
Medical Device News
@FierceMedDev: ICYMI yesterday: Google wearables to add to planned bioinformatics database. Article | Follow @FierceMedDev
@StacyALawrence: Medtronic teaming up with China's LifeTech to develop cardiovascular products. More | Follow @StacyALawrence
@VarunSaxena2: FDA final guidance modifies 510(k) rules, discourages use of multiple predicate devices. Story | Follow @VarunSaxena2
@MichaelGFierce: Scientists test a Nanoparticle "Alarm Clock" to Awaken Immune Systems Put to Sleep by Cancer. More from Newswise | Follow @MichaelGFierce
@EmilyWFierce: FDA and physicians question the validity of popular mobile medical health apps. More from Wired | Follow @EmilyWFierce
> Wearable optical device detects diabetic complication. More
> Proteus Digital adds $52M to Series G, bringing total to $172M. News
> French devicemaker faces FDA scrutiny for prostate cancer device. Article
Biotech News
@FierceBiotech: Nominations are open for our 2014 Women in Biotech report. More | Nomination form | Follow @FierceBiotech
@JohnCFierce: Resurgent Merck to accelerate R&D spending in H2, hunt new drug deals. Article | Follow @JohnCFierce
@DamianFierce: $GSK has launched Tanzeum (albiglutide) in the U.S., further crowding the GLP-1 market for T2 diabetes. Press release | Follow @DamianFierce
@EmilyMFierce: Really cool, albeit potentially terrifying: Teeth Sprout from Glia-Derived Stem Cells. GEN piece | Follow @EmilyMFierce
> Pfizer, Lilly and J&J chip in on $51M seed fund for New York biotechs. News
> Targacept's litany of trial failures continues with yet another flop. Article
> Sanofi dumps KaloBios' antibiotic in another stinging setback. More
Biotech Research News
> NIH to spur innovation in new therapeutic areas. News
> Janssen rethinks drug discovery in a changing R&D environment. More
> Anti-inflammatory drug stops Parkinson's neuron loss in rats. Article
> CDC takes steps to improve lab safety after anthrax, flu scares. Story
> Vaccine protects animals against dust mite allergies. Item
Pharma Manufacturing News
> Impax now faces FDA issues at Taiwan plant that could affect Rytary. Report
> PCI buys contract manufacturer Penn Pharma in $215M deal. Story
> Merck KGaA to cut carbon dioxide emissions at Darmstadt site. More
> Hikma buys closed Boehringer plant and strips out equipment. News
> J&J done with Boehringer plant after building a supply of Doxil. Article
And Finally... The quantified-fitness company Jawbone launched an app to track caffeine consumption, UP Coffee. Report